Hecht Beth
SEC insider (Form 3/4/5 filer). CIK 0001652410. Officer at Xeris Biopharma Holdings, Inc. (XERS). 22 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in CHICAGO, IL.
Companies Hecht Beth has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Officer, See Remarks
Hecht Beth
CIK: 0001652410
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xeris Biopharma Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Oct 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $9.41$157K - Sep 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $8.49$141K - Aug 3, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $8.01$134K - Jul 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $8.03$134K - Jun 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $6.06$101K - May 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $6.23$104K - Apr 1, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $5.99$100K - Mar 2, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect100 shares at avg. $7.06$706 - Mar 2, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.6K shares at avg. $6.24$103K - Feb 2, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect16.7K shares at avg. $7.45$124K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,666 | $9.41 | $156,792 | Direct |
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,666 | $8.49 | $141,434 | Direct |
| Aug 3, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,666 | $8.01 | $133,553 | Direct |
| Jul 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,666 | $8.03 | $133,860 | Direct |
| Jun 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,667 | $6.06 | $100,982 | Direct |
| May 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,667 | $6.23 | $103,805 | Direct |
| Apr 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,667 | $5.99 | $99,859 | Direct |
| Mar 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 100 | $7.06 | $706 | Direct |
| Mar 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,567 | $6.24 | $103,380 | Direct |
| Feb 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 16,667 | $7.45 | $124,147 | Direct |
1-10 of 22 transactions